- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2010 (2010), Article ID 306462, 6 pages
In Vivo Bioassay of Recombinant Human Growth Hormone Synthesized in B. mori Pupae
1College of Life Sciences, Zhejiang University, Hangzhou 310058, China
2Institute of Biochemistry, Zhejiang Sci-Tech University, Hangzhou 310018, China
3School of Applied Technology, Zhejiang Economic & Trade Polytechnic, Hangzhou 310018, China
Received 26 July 2009; Revised 13 December 2009; Accepted 15 January 2010
Academic Editor: Mark Smith
Copyright © 2010 Hanglian Lan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- D. Le Roith, C. Bondy, S. Yakar, J.-L. Liu, and A. Butler, “The somatomedin hypothesis: 2001,” Endocrine Reviews, vol. 22, no. 1, pp. 53–74, 2001.
- R. Mukhija, P. Rupa, D. Pillai, and L. C. Garg, “High-level production and one-step purification of biologically active human growth hormone in Escherichia coli,” Gene, vol. 165, no. 2, pp. 303–306, 1995.
- C. di Guan, P. Li, P. D. Riggs, and H. Inouye, “Vectors that facilitate the expression and purification of foreign peptides in Escherichia coli by fusion to maltose-binding protein,” Gene, vol. 67, no. 1, pp. 21–30, 1988.
- E. R. LaVallie, E. A. DiBlasio, S. Kovacic, K. L. Grant, P. F. Schendel, and J. M. McCoy, “A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm,” Nature Biotechnology, vol. 11, no. 2, pp. 187–193, 1993.
- Z. H. Geng and P. Gao, “Expression of human growth hormone gene in Bac-to-Bac Baculorirus system,” Chinese Journal of Biochemistry and Molecular Biology, vol. 18, p. 5, 2003.
- R. L. Hawkins and M. Nakamura, “Expression of human growth hormone by the eukaryotic alga, Chlorella,” Current Microbiology, vol. 38, no. 6, pp. 335–341, 1999.
- M. D. Summers and G. D. Smith, A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures (Texas Agricultural Experiment Station Bulletin), vol. 1555, Texas Agricultural Experiment Station, 1987.
- F. S. Greenspan, C. H. Li, M. E. Simpson, and H. M. Evans, “Bioassay of hypophyseal growth hormone: the tibia test,” Endocrinology, vol. 45, pp. 455–463, 1949.
- S. Inumaru and S. Yamada, “Characterization of pseudorabies virus neutralization antigen glycoprotein gIII produced in insect cells by a baculovirus expression vector,” Virus Research, vol. 21, no. 2, pp. 123–139, 1991.
- L. L. Li, Baculovirus Expression Vectors, Huazhong Normal University Press, Wuhan, China, 1996.
- F. M. Ausubel, R. Brent, R. E. Kingston, et al., Current Protocls in Molecular Biology, Greene Publishing Associates, New York, NY, USA, 1993.
- J. Z. Wang and M. Fan, Protein Technical Manual, Science Press, Beijing, China, 2000.
- C. J. Zhu, “Construction and selection of hypox rats,” Chinese Phamacological Bulletin, vol. 13, p. 4, 1997.
- C. Gauwerky, D. W. Golde, and C. H. Li, “Growth hormone polypeptides stimulate proliferation of k562 human erythroleukemia cells,” Journal of Clinical Endocrinology and Metabolism, vol. 51, no. 4, pp. 1208–1210, 1980.
- S. Maeda, T. Kawai, and M. Obinata, “Production of human -interferon in silkworm using a baculovirus vector,” Nature, vol. 315, no. 6020, pp. 592–594, 1985.
- T. Liu, Y.-Z. Zhang, and X.-F. Wu, “High level expression of functionally active human lactoferrin in silkworm larvae,” Journal of Biotechnology, vol. 118, no. 3, pp. 246–256, 2005.
- K. Kadono-Okuda, M. Yamamoto, Y. Higashino, et al., “Baculovirus-mediated production of the human growth hormone in larvae of the silkworm, Bombyx mori,” Biochemical and Biophysical Research Communications, vol. 213, no. 2, pp. 389–396, 1995.
- T. Suzuki, T. Kanaya, H. Okazaki, et al., “Efficient protein production using a Bombyx mori nuclear polyhedrosis virus lacking the cysteine proteinase gene,” Journal of General Virology, vol. 78, no. 12, pp. 3073–3080, 1997.
- C. Ohlsson, B.-Å. Bengtsson, O. G. P. Isaksson, T. T. Andreassen, and M. C. Slootweg, “Growth hormone and bone,” Endocrine Reviews, vol. 19, no. 1, pp. 55–79, 1998.
- G. P. Talwar, M. R. Pandian, and N. Kumar, “Mechanism of action of pituitary growth hormone,” Recent Progress in Hormone Research, vol. 31, pp. 141–174, 1975.
- P. S. Rudland, R. C. Hallowes, H. Durbin, and D. Lewis, “Mitogenic activity of pituitary hormones on cell cultures of normal and carcinogen induced tumor epithelium from rat mammary glands,” Journal of Cell Biology, vol. 73, no. 3, pp. 561–577, 1977.
- J. H. Nielsen, K. Brunstedt, R. Jorgensen, and D. Jensen, “Direct long-term effect of growth hormone and prolactin on growth and function of pancreatic islets in tissue culture,” Diabetologia, vol. 15, no. 3, p. 258, 1978.
- D. R. Bangham, R. E. G. Das, and D. Schulster, “The International standard for human growth hormone for bioassay: calibration and characterization by international collaborative study,” Molecular and Cellular Endocrinology, vol. 42, no. 3, pp. 269–282, 1985.
- Y. Zhang, J. Chen, Z. Lv, Z. Nie, X. Zhang, and X. Wu, “Can 29 kDa rhGM-CSF expressed by silkworm pupae bioreactor bring into effect as active cytokine through orally administration?” European Journal of Pharmaceutical Sciences, vol. 28, no. 3, pp. 212–223, 2006.
- W. Zhang, Z. Lv, Z. Nie, et al., “Bioavailability of orally administered rhGM-CSF: a single-dose, randomized, open-label, two-period crossover trial,” PLoS ONE, vol. 4, no. 5, article e5353, 2009.
- Z. Gong, Y. Jin, and Y. Zhang, “Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm,” Vaccine, vol. 25, no. 8, pp. 1444–1451, 2007.
- Z. Gong, Y. Jin, and Y. Zhang, “Oral administration of a cholera toxin B subunit-insulin fusion protein produced in silkworm protects against autoimmune diabetes,” Journal of Biotechnology, vol. 119, no. 1, pp. 93–105, 2005.
- H.-L. Xiao, Y.-Z. Zhang, and X.-F. Wu, “Oral administration activity determination of recombinant osteoprotegerin from silkworm larvae,” Molecular Biotechnology, vol. 35, no. 2, pp. 179–184, 2007.